Source 1R01HL164854-01A1, NHLBI
Role Principal Investigator
Title Roles of SARM1 NAD+ hydrolase in metabolic cardiomyopathy
Period June 2023 – May 2028
Source Oklahoma Biotech Startup Program (OKBiostart), University of Oklahoma
Role Principal Investigator
Title Development of a cell-based screening assay to identify novel SARM1 inhibitors
Period September 2023 – August 2024
Source PHF Technology Enabling Grant, Presbyterian Health Foundation (PHF)
Role Principal Investigator
Title Determine the role of activated SARM1 NAD+ hydrolase in heart disease
Period July 2022 – June 2024